Latest Breaking News On - Prof bin cao - Page 1 : comparemela.com

Half of patients hospitalised with Covid have symptoms after two years, study shows

Half of patients hospitalised with Covid have symptoms after two years, study shows
bristolpost.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bristolpost.co.uk Daily Mail and Mail on Sunday newspapers.

Jin yin tanLancet respiratory medicineProf bin caoChina japan friendshipJin yin tan hospital

Long COVID: Wuhan patients still have symptoms two years later

Two years after COVID-19 infection, over half of people hospitalised are still experiencing at least one symptom, according to the longest follow-up study so far.

Lancet respiratory medicineLong covidProf bin caoChina japan friendship

Half of Covid-hospitalised still symptomatic two years on, study finds

Research on Wuhan patients reveals effects of long Covid, with 11% still not having returned to work

Jin yin tanLancet respiratoryProf bin caoJin yin tan hospitalLancet respiratory medicine

CoronaVac safe for children and teenagers, a new study indicates

This is the first vaccine to test immunology in children as young as three years old. The most reported side effect was injection-site pain. A new study has found that two doses of the CoronaVac vaccine were safe and well-tolerated in children and adolescents aged three to 17 years old. The research published in The Lancet is the first to report on the immunogenicity and safety of a Covid-19 candidate vaccine in children as young as three years. CoronaVac was on Saturday approved for use in South Africa - with conditions - by the South African Health Products Regulatory (Sahpra). The regulator, however, only approved the vaccine for adults aged between 18 and 59. The authorisation was based on the safety, quality and efficacy data submitted by Curanto Pharma to Sahpra between 22 March and 22 June, according to a News24 report.

South africaAfrican health products regulatory sahpraSouth african health products regulatoryCuranto pharmaChinese sinovacProf bin cao